Platelet-derived microparticles promote invasiveness of prostate cancer cells via upregulation of MMP-2 production

International Journal of Cancer

Volumn 124, Issue 8, 2009, Pages 1773-1777

  Dashevsky, Olga ^a   Varon, David ^a   Brill, Alexander ^a,b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

MMP 2; Platelet derived microparticles; Prostate cancer

Indexed keywords

CYCLOHEXIMIDE; DACTINOMYCIN; GELATINASE A; GELATINASE INHIBITOR; GELATIN; PROTEIN SYNTHESIS INHIBITOR;

ARTICLE; CANCER CELL; CANCER INVASION; CONTROLLED STUDY; HUMAN; HUMAN CELL; PLATELET MICROPARTICLE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; UPREGULATION; BLOOD; CELL ADHESION; CHEMISTRY; CULTURE TECHNIQUE; CYTOPLASM; GENE EXPRESSION REGULATION; INSTRUMENTATION; MALE; METABOLISM; PATHOLOGY; PROSTATE TUMOR; THROMBOCYTE; TIME;

BLOOD PLATELETS; CELL ADHESION; CELL CULTURE TECHNIQUES; CYCLOHEXIMIDE; CYTOPLASM; DACTINOMYCIN; GELATIN; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; PROSTATIC NEOPLASMS; PROTEIN SYNTHESIS INHIBITORS; TIME FACTORS; UP-REGULATION;

EID: 62449209166     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.24016     Document Type: Article

References (26)

1. Gasic GJ, Gasic TB, Stewart CC. Antimetastatic effects associated with platelet reduction. Proc Natl Acad Sci USA 1968;61:46-52.
2. Camerer E, Qazi AA, Duong DN, Cornelissen I, Advincula R, Coughlin SR. Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis. Blood 2004;104:397-401. (Pubitemid 38900020)
3. Boucharaba A, Serre CM, Gres S, Saulnier-Blache JS, Bordet JC, Guglielmi J, Clezardin P, Peyruchaud O. Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer. J Clin Invest 2004;114:1714-1725 (Pubitemid 40385527)
4. Dardik R, Kaufmann Y, Savion N, Rosenberg N, Shenkman B, Varon D. Platelets mediate tumor cell adhesion to the subendothelium under flow conditions: involvement of platelet GPIIb-IIIa and tumor cell alpha(v) integrins. Int J Cancer 1997;70:201-207
5. Trikha M, Nakada MT. Platelets and cancer: implications for antiangiogenic therapy. Semin Thromb Hemost 2002;28:39-44. (Pubitemid 34194871)
6. Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol 2002;29:15-18.
7. Brill A, Elinav H, Varon D. Differential role of platelet granular mediators in angiogenesis. Cardiovasc Res 2004;63:226-235 (Pubitemid 38900837)
8. Rhee JS, Black M, Schubert U, Fischer S, Morgenstern E, Hammes HP, Preissner KT. The functional role of blood platelet components in angiogenesis. Thromb Haemost 2004;92:394-402. (Pubitemid 39177413)
9. Yoon SO, Park SJ, Yun CH, Chung AS. Roles of matrix metalloproteinases in tumor metastasis and angiogenesis. J Biochem Mol Biol 2003;36:128-137 (Pubitemid 36836264)
10. Somiari SB, Somiari RI, Heckman CM, Olsen CH, Jordan RM, Russell SJ, Shriver CD. Circulating MMP2 and MMP9 in breast cancer - potential role in classification of patients into low risk, high risk, benign disease and breast cancer categories. Int J Cancer 2006;119:1403-1411 (Pubitemid 44258818)
11. Kim HK, Song KS, Park YS, Kang YH, Lee YJ, Lee KR, Kim HK, Ryu KW, Bae JM, Kim S. Elevated levels of circulating platelet microparticles. VEGF, IL-6 and. RANTES in patients with gastric cancer: possible role of a metastasis predictor. Eur J Cancer 2003;39:184-191
12. Janowska-Wieczorek A, Wysoczynski M, Kijowski J, Marquez-Curtis L, Machalinski B, Ratajczak J, Ratajczak MZ. Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer. Int J Cancer 2005;113:752-760 (Pubitemid 40101256)
13. Janowska-Wieczorek A, Marquez-Curtis LA, Wysoczynski M, Ratajczak MZ. Enhancing effect of platelet-derived microvesicles on the invasive potential of breast cancer cells. Transfusion 2006;46:1199-1209 (Pubitemid 44139495)
14. Bhatti RA, Gadarowski J, Ray P. Potential role of platelets and coagulation factors in the metastasis of prostatic cancer. Invasion Metastasis 1996;16:49-55. (Pubitemid 27052763)
15. Brill A, Dashevsky O, Rivo J, Gozal Y, Varon D. Platelet-derived microparticles induce angiogenesis and stimulate post-ischemic revascularization. Cardiovasc Res 2005;67:30-38 (Pubitemid 40798290)
16. Kuo L, Chang HC, Leu TH, Maa MC, Hung WC. Src oncogene activates MMP-2 expression via the ERK/Sp1 pathway. J Cell Physiol 2006;207:729-734 (Pubitemid 43668237)
17. Zhong J, Gencay MM, Bubendorf L, Burgess JK, Parson H, Robinson BW, Tamm M, Black JL, Roth M. ERK1/2 and p38 MAP kinase control MMP-2. MT1-MMP, and. TIMP action and affect cell migration: a comparison between mesothelioma and mesothelial cells. J Cell Physiol 2006;207:540-552
18. Karpatkin S, Pearlstein E. Role of platelets in tumor cell metastases. Ann Intern Med 1981;95:636-641 (Pubitemid 12231807)
19. Gupta GP, Massague J. Platelets and metastasis revisited: a novel fatty link. J Clin Invest 2004;114:1691-1693 (Pubitemid 40385522)
20. Burdick MM, Konstantopoulos K Platelet-induced enhancement of LS174T colon carcinoma and THP-1 monocytoid cell adhesion to vascular endothelium under flow. Am J Physiol Cell Physiol 2004; 287:C539-47.
21. Do TV, Symowicz JC, Berman DM, Liotta LA, Petricoin EF, 3rd, Stack MS, Fishman DA. Lysophosphatidic acid down-regulates stress fibers and up-regulates pro-matrix metalloproteinase-2 activation in ovarian cancer cells. Mol Cancer Res 2007;5:121-131
22. Guo R, Kasbohm EA, Arora P, Sample CJ, Baban B, Sud N, Sivashanmugam P, Moniri NH, Daaka Y. Expression and function of lysophosphatidic acid LPA1 receptor in prostate cancer cells. Endocrinology 2006;147:4883-4892 (Pubitemid 44402195)
23. Fourcade O, Simon MF, Viode C, Rugani N, Leballe F, Ragab A, Fournie B, Sarda L, Chap H. Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell 1995;80:919-927
24. Hao F, Tan M, Xu X, Han J, Miller DD, Tigyi G, Cui MZ. Lysophosphatidic acid induces prostate cancer PC3 cell migration via activation of LPA(1), p42 and p38alpha. Biochim Biophys Acta 2007;1771: 883-892
25. Husain S, Jafri F, Crosson CE. Acute effects of PGF2alpha on MMP-2 secretion from human ciliary muscle cells: a PKC- and ERK-dependent process. Invest Ophthalmol Vis Sci 2005;46:1706-1713
26. Eberhardt W, Doller A, Akool ES, Pfeilschifter J. Modulation of mRNA stability as a novel therapeutic approach. Pharmacol Ther 2007;114:56-73. (Pubitemid 46498160)